Skip to main content
Erschienen in: Journal of Translational Medicine 1/2013

Open Access 01.12.2013 | Research

Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer

verfasst von: Yun-Peng Peng, Yi Zhu, Jing-Jing Zhang, Ze-Kuan Xu, Zhu-Yin Qian, Cun-Cai Dai, Kui-Rong Jiang, Jun-Li Wu, Wen-Tao Gao, Qiang Li, Qing Du, Yi Miao

Erschienen in: Journal of Translational Medicine | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Digestive malignancies, especially pancreatic cancer (PC), gastric cancer (GC), and colorectal cancer (CRC), still occur at persistently high rates, and disease progression in these cancers has been associated with tumor immunosurveillance escape. Natural killer (NK) cell dysfunction may be responsible for this phenomenon, however, the exact relationship between tumor immunosurveillance escape in digestive malignancies and NK cell dysfunction remains unclear.

Methods

Percentage of the surface receptors NKG2A, KIR3DL1, NKG2D, NKp30, NKp44, NKp46, and DNAM-1, as well as the cytotoxic granules perforin and granzyme B positive NK cells were determined in patients with pancreatic cancer (n = 31), gastric cancer (n = 31), and CRC (n = 32) prior to surgery and healthy controls (n = 31) by multicolor flow cytometry. Independent t-tests or Mann-Whitney U-tests were used to compare the differences between the patient and healthy control groups, as well as the differences between patients with different pathologic features of cancer.

Results

Percentage of NKG2D, NKp30, NKp46, and perforin positive NK cells was significantly down-regulated in patients with PC compared to healthy controls, as well as GC and CRC; reduced levels of these molecules was associated with indicators of disease progression in each malignancy (such as histological grade, depth of invasion, lymph node metastasis). On the contrary, percentage of KIR3DL1 positive NK cells was significantly increased in patients with PC, as well as GC and CRC, but was not associated with any indicators of disease progression.

Conclusions

Altered percentage of surface receptors and cytotoxic granules positive NK cells may play a vital role in tumor immunosurveillance escape by inducing NK cell dysfunction in patients with PC, GC, and CRC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Zavoral M, Minarikova P, Zavada F, Salek C, Minarik M: Molecular biology of pancreatic cancer. World J Gastroenterol. 2011, 17: 2897-2908. 10.3748/wjg.v17.i24.2897.PubMedCentralCrossRefPubMed Zavoral M, Minarikova P, Zavada F, Salek C, Minarik M: Molecular biology of pancreatic cancer. World J Gastroenterol. 2011, 17: 2897-2908. 10.3748/wjg.v17.i24.2897.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62: 10-29. 10.3322/caac.20138.CrossRefPubMed Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62: 10-29. 10.3322/caac.20138.CrossRefPubMed
3.
Zurück zum Zitat Lowenfels AB, Maisonneuve P: Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006, 20: 197-209. 10.1016/j.bpg.2005.10.001.CrossRefPubMed Lowenfels AB, Maisonneuve P: Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006, 20: 197-209. 10.1016/j.bpg.2005.10.001.CrossRefPubMed
4.
Zurück zum Zitat Konjevic G, Jurisic V, Jovic V, Vuletic A, Martinovic MK, Radenkovic S, Spuzic I: Investigation of NK cell function and their modulation in different malignancies. Immunol Res. 2012, 52: 139-156. 10.1007/s12026-012-8285-7.CrossRefPubMed Konjevic G, Jurisic V, Jovic V, Vuletic A, Martinovic MK, Radenkovic S, Spuzic I: Investigation of NK cell function and their modulation in different malignancies. Immunol Res. 2012, 52: 139-156. 10.1007/s12026-012-8285-7.CrossRefPubMed
5.
Zurück zum Zitat Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH: NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol. 1996, 156: 4707-4714.PubMed Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH: NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol. 1996, 156: 4707-4714.PubMed
6.
Zurück zum Zitat Walzer T, Jaeger S, Chaix J, Vivier E: Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol. 2007, 19: 365-372. 10.1016/j.coi.2007.04.004.CrossRefPubMed Walzer T, Jaeger S, Chaix J, Vivier E: Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol. 2007, 19: 365-372. 10.1016/j.coi.2007.04.004.CrossRefPubMed
7.
Zurück zum Zitat Bensussan A, Remtoula N, Sivori S, Bagot M, Moretta A, Marie-Cardine A: Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sezary syndrome patients. J Invest Dermatol. 2011, 131: 969-976. 10.1038/jid.2010.404.CrossRefPubMed Bensussan A, Remtoula N, Sivori S, Bagot M, Moretta A, Marie-Cardine A: Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sezary syndrome patients. J Invest Dermatol. 2011, 131: 969-976. 10.1038/jid.2010.404.CrossRefPubMed
8.
Zurück zum Zitat Correia DV, Fogli M, Hudspeth K, da Silva MG, Mavilio D, Silva-Santos B: Differentiation of human peripheral blood Vdelta1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood. 2011, 118: 992-1001. 10.1182/blood-2011-02-339135.CrossRefPubMed Correia DV, Fogli M, Hudspeth K, da Silva MG, Mavilio D, Silva-Santos B: Differentiation of human peripheral blood Vdelta1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood. 2011, 118: 992-1001. 10.1182/blood-2011-02-339135.CrossRefPubMed
9.
Zurück zum Zitat Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001, 19: 197-223. 10.1146/annurev.immunol.19.1.197.CrossRefPubMed Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001, 19: 197-223. 10.1146/annurev.immunol.19.1.197.CrossRefPubMed
10.
Zurück zum Zitat Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999, 285: 727-729. 10.1126/science.285.5428.727.CrossRefPubMed Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999, 285: 727-729. 10.1126/science.285.5428.727.CrossRefPubMed
11.
Zurück zum Zitat Bryceson YT, Ljunggren HG: Tumor cell recognition by the NK cell activating receptor NKG2D. Eur J Immunol. 2008, 38: 2957-2961. 10.1002/eji.200838833.CrossRefPubMed Bryceson YT, Ljunggren HG: Tumor cell recognition by the NK cell activating receptor NKG2D. Eur J Immunol. 2008, 38: 2957-2961. 10.1002/eji.200838833.CrossRefPubMed
12.
Zurück zum Zitat Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science. 2011, 331: 44-49. 10.1126/science.1198687.PubMedCentralCrossRefPubMed Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science. 2011, 331: 44-49. 10.1126/science.1198687.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N: Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med. 2003, 198: 557-567. 10.1084/jem.20030788.PubMedCentralCrossRefPubMed Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N: Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med. 2003, 198: 557-567. 10.1084/jem.20030788.PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Parham P, Norman PJ, Abi-Rached L, Guethlein LA: Variable NK cell receptors exemplified by human KIR3DL1/S1. J Immunol. 2011, 187: 11-19. 10.4049/jimmunol.0902332.PubMedCentralCrossRefPubMed Parham P, Norman PJ, Abi-Rached L, Guethlein LA: Variable NK cell receptors exemplified by human KIR3DL1/S1. J Immunol. 2011, 187: 11-19. 10.4049/jimmunol.0902332.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V: Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999, 286: 1957-1959. 10.1126/science.286.5446.1957.CrossRefPubMed Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V: Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999, 286: 1957-1959. 10.1126/science.286.5446.1957.CrossRefPubMed
16.
Zurück zum Zitat Chowdhury D, Lieberman J: Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol. 2008, 26: 389-420. 10.1146/annurev.immunol.26.021607.090404.PubMedCentralCrossRefPubMed Chowdhury D, Lieberman J: Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol. 2008, 26: 389-420. 10.1146/annurev.immunol.26.021607.090404.PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Bhat R, Watzl C: Serial killing of tumor cells by human natural killer cells–enhancement by therapeutic antibodies. PLoS One. 2007, 2: e326-10.1371/journal.pone.0000326.PubMedCentralCrossRefPubMed Bhat R, Watzl C: Serial killing of tumor cells by human natural killer cells–enhancement by therapeutic antibodies. PLoS One. 2007, 2: e326-10.1371/journal.pone.0000326.PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Farag SS, Caligiuri MA: Human natural killer cell development and biology. Blood Rev. 2006, 20: 123-137. 10.1016/j.blre.2005.10.001.CrossRefPubMed Farag SS, Caligiuri MA: Human natural killer cell development and biology. Blood Rev. 2006, 20: 123-137. 10.1016/j.blre.2005.10.001.CrossRefPubMed
19.
Zurück zum Zitat McGilvray RW, Eagle RA, Watson NF, Al-Attar A, Ball G, Jafferji I, Trowsdale J, Durrant LG: NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting. Clin Cancer Res. 2009, 15: 6993-7002. 10.1158/1078-0432.CCR-09-0991.PubMedCentralCrossRefPubMed McGilvray RW, Eagle RA, Watson NF, Al-Attar A, Ball G, Jafferji I, Trowsdale J, Durrant LG: NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting. Clin Cancer Res. 2009, 15: 6993-7002. 10.1158/1078-0432.CCR-09-0991.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Hilpert J, Grosse-Hovest L, Grunebach F, Buechele C, Nuebling T, Raum T, Steinle A, Salih HR: Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses. J Immunol. 2012, 189: 1360-1371. 10.4049/jimmunol.1200796.CrossRefPubMed Hilpert J, Grosse-Hovest L, Grunebach F, Buechele C, Nuebling T, Raum T, Steinle A, Salih HR: Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses. J Immunol. 2012, 189: 1360-1371. 10.4049/jimmunol.1200796.CrossRefPubMed
21.
Zurück zum Zitat Garcia-Iglesias T, Del Toro-Arreola A, Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE, Ramirez-Duenas MG, Balderas-Pena LM, Bravo-Cuellar A, Ortiz-Lazareno PC, Daneri-Navarro A: Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer. 2009, 9: 186-10.1186/1471-2407-9-186.PubMedCentralCrossRefPubMed Garcia-Iglesias T, Del Toro-Arreola A, Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE, Ramirez-Duenas MG, Balderas-Pena LM, Bravo-Cuellar A, Ortiz-Lazareno PC, Daneri-Navarro A: Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer. 2009, 9: 186-10.1186/1471-2407-9-186.PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P, Romagne F, Thibault G: Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011, 121: 3609-3622. 10.1172/JCI45816.PubMedCentralCrossRefPubMed Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P, Romagne F, Thibault G: Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011, 121: 3609-3622. 10.1172/JCI45816.PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S: Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res. 2012, 72: 1407-1415. 10.1158/0008-5472.CAN-11-2544.CrossRefPubMed Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S: Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res. 2012, 72: 1407-1415. 10.1158/0008-5472.CAN-11-2544.CrossRefPubMed
24.
Zurück zum Zitat Koch J, Steinle A, Watzl C, Mandelboim O: Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol. 2013, 34: 182-191. 10.1016/j.it.2013.01.003.CrossRefPubMed Koch J, Steinle A, Watzl C, Mandelboim O: Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol. 2013, 34: 182-191. 10.1016/j.it.2013.01.003.CrossRefPubMed
25.
Zurück zum Zitat Hecht ML, Rosental B, Horlacher T, Hershkovitz O, De Paz JL, Noti C, Schauer S, Porgador A, Seeberger PH: Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res. 2009, 8: 712-720. 10.1021/pr800747c.CrossRefPubMed Hecht ML, Rosental B, Horlacher T, Hershkovitz O, De Paz JL, Noti C, Schauer S, Porgador A, Seeberger PH: Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res. 2009, 8: 712-720. 10.1021/pr800747c.CrossRefPubMed
26.
Zurück zum Zitat Kaifu T, Escaliere B, Gastinel LN, Vivier E, Baratin M: B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors. Cell Mol Life Sci. 2011, 68: 3531-3539. 10.1007/s00018-011-0802-7.CrossRefPubMed Kaifu T, Escaliere B, Gastinel LN, Vivier E, Baratin M: B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors. Cell Mol Life Sci. 2011, 68: 3531-3539. 10.1007/s00018-011-0802-7.CrossRefPubMed
27.
Zurück zum Zitat von Strandmann PE, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, Rothe A, Boll B, Simhadri VL, Borchmann P: Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity. 2007, 27: 965-974. 10.1016/j.immuni.2007.10.010.CrossRef von Strandmann PE, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, Rothe A, Boll B, Simhadri VL, Borchmann P: Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity. 2007, 27: 965-974. 10.1016/j.immuni.2007.10.010.CrossRef
28.
Zurück zum Zitat Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, Stolovich-Rain M, Nir T, Achdout H, Glaser B, Shapiro J: Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J Immunol. 2011, 187: 3096-3103. 10.4049/jimmunol.1101269.CrossRefPubMed Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, Stolovich-Rain M, Nir T, Achdout H, Glaser B, Shapiro J: Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J Immunol. 2011, 187: 3096-3103. 10.4049/jimmunol.1101269.CrossRefPubMed
29.
Zurück zum Zitat Hudspeth K, Silva-Santos B, Mavilio D: Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. Front Immunol. 2013, 4: 69-PubMedCentralCrossRefPubMed Hudspeth K, Silva-Santos B, Mavilio D: Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. Front Immunol. 2013, 4: 69-PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Gasser S, Orsulic S, Brown EJ, Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005, 436: 1186-1190. 10.1038/nature03884.PubMedCentralCrossRefPubMed Gasser S, Orsulic S, Brown EJ, Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005, 436: 1186-1190. 10.1038/nature03884.PubMedCentralCrossRefPubMed
31.
Zurück zum Zitat Castriconi R, Cantoni C, Della CM, Vitale M, Marcenaro E, Conte R, Biassoni R, Bottino C, Moretta L, Moretta A: Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci USA. 2003, 100: 4120-4125. 10.1073/pnas.0730640100.PubMedCentralCrossRefPubMed Castriconi R, Cantoni C, Della CM, Vitale M, Marcenaro E, Conte R, Biassoni R, Bottino C, Moretta L, Moretta A: Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci USA. 2003, 100: 4120-4125. 10.1073/pnas.0730640100.PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Della Chiesa M, Carlomagno S, Frumento G, Balsamo M, Cantoni C, Conte R, Moretta L, Moretta A, Vitale M: The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood. 2006, 108: 4118-4125. 10.1182/blood-2006-03-006700.CrossRefPubMed Della Chiesa M, Carlomagno S, Frumento G, Balsamo M, Cantoni C, Conte R, Moretta L, Moretta A, Vitale M: The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood. 2006, 108: 4118-4125. 10.1182/blood-2006-03-006700.CrossRefPubMed
33.
Zurück zum Zitat Saito H, Osaki T, Ikeguchi M: Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer. Gastric Cancer. 2012, 15: 27-33.CrossRefPubMed Saito H, Osaki T, Ikeguchi M: Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer. Gastric Cancer. 2012, 15: 27-33.CrossRefPubMed
34.
Zurück zum Zitat Duan X, Deng L, Chen X, Lu Y, Zhang Q, Zhang K, Hu Y, Zeng J, Sun W: Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Med Oncol. 2011, 28: 466-474. 10.1007/s12032-010-9480-9.CrossRefPubMed Duan X, Deng L, Chen X, Lu Y, Zhang Q, Zhang K, Hu Y, Zeng J, Sun W: Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Med Oncol. 2011, 28: 466-474. 10.1007/s12032-010-9480-9.CrossRefPubMed
35.
Zurück zum Zitat Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Raulet DH: NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 2008, 28: 571-580. 10.1016/j.immuni.2008.02.016.PubMedCentralCrossRefPubMed Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Raulet DH: NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 2008, 28: 571-580. 10.1016/j.immuni.2008.02.016.PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Salih HR, Rammensee HG, Steinle A: Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol. 2002, 169: 4098-4102.CrossRefPubMed Salih HR, Rammensee HG, Steinle A: Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol. 2002, 169: 4098-4102.CrossRefPubMed
37.
Zurück zum Zitat Smyth MJ, Swann J, Kelly JM, Cretney E, Yokoyama WM, Diefenbach A, Sayers TJ, Hayakawa Y: NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med. 2004, 200: 1325-1335. 10.1084/jem.20041522.PubMedCentralCrossRefPubMed Smyth MJ, Swann J, Kelly JM, Cretney E, Yokoyama WM, Diefenbach A, Sayers TJ, Hayakawa Y: NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med. 2004, 200: 1325-1335. 10.1084/jem.20041522.PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Peruzzi M, Parker KC, Long EO, Malnati MS: Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol. 1996, 157: 3350-3356.PubMed Peruzzi M, Parker KC, Long EO, Malnati MS: Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol. 1996, 157: 3350-3356.PubMed
39.
Zurück zum Zitat Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, Field JK, Christmas SE: Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Hum Immunol. 2010, 71: 976-981. 10.1016/j.humimm.2010.06.019.CrossRefPubMed Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, Field JK, Christmas SE: Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Hum Immunol. 2010, 71: 976-981. 10.1016/j.humimm.2010.06.019.CrossRefPubMed
Metadaten
Titel
Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer
verfasst von
Yun-Peng Peng
Yi Zhu
Jing-Jing Zhang
Ze-Kuan Xu
Zhu-Yin Qian
Cun-Cai Dai
Kui-Rong Jiang
Jun-Li Wu
Wen-Tao Gao
Qiang Li
Qing Du
Yi Miao
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
Journal of Translational Medicine / Ausgabe 1/2013
Elektronische ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-262

Weitere Artikel der Ausgabe 1/2013

Journal of Translational Medicine 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.